Anzeige
Mehr »
Login
Samstag, 13.08.2022 Börsentäglich über 12.000 News von 669 internationalen Medien
Innocan Pharma: 15 Mal besser als der Status Quo!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PUSM ISIN: SE0013121340 Ticker-Symbol: MB8A 
Frankfurt
12.08.22
17:14 Uhr
0,175 Euro
-0,003
-1,47 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MOBERG PHARMA AB Chart 1 Jahr
5-Tage-Chart
MOBERG PHARMA AB 5-Tage-Chart

Aktuelle News zur MOBERG PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiMoberg Pharma Q2 EBITDA SEK -4.3 Million110(PLX AI) - Moberg Pharma Q2 EBIT SEK -4.9 million.• Q2 net income SEK -3.9 million• Q2 EPS SEK -0.06
► Artikel lesen
DiMoberg Pharma's interim report January - June 20221
04.08.Moberg Pharma and Padagis sign agreement for MOB-015 in Israel1
MOBERG PHARMA Aktie jetzt für 0€ handeln
30.06.New number of shares and votes in Moberg Pharma AB (publ)2
10.06.Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Moberg Pharma AB (publ) (104/22)181Trading in Moberg Pharma AB (publ)paid subscription shares is to cease. The last trading day is June 14, 2022. Short name: MOB BTA --------------------------- ISIN code: SE0017859085 --------------------------- Orderbook...
► Artikel lesen
08.06.Moberg Pharma resolves on a directed issue of ordinary shares to guarantors in connection with the completed rights issue1
08.06.MOBERG PHARMA: The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares1
31.05.Moberg Pharma announces outcome of rights issue of ordinary shares1
16.05.Bulletin from Moberg Pharma's AGM on May 16[th], 2022-
12.05.Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Moberg Pharma AB (publ) (70/22)199With effect from May 13, 2022, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including May 23, 2022. Instrument: Subscription...
► Artikel lesen
11.05.Moberg Pharma publishes prospectus relating to the rights issue-
10.05.Moberg Pharma's Interim report January - March 2022-
10.05.Moberg Pharma begins patient enrollment in North American phase 3 study-
09.05.XFRA CAPITAL ADJUSTMENT INFORMATION - 09.05.2022291Das Instrument IXA FR0000030827 IGE + XAO S.A.INH.EO 3,85 EQUITY wird cum Kapitalmassnahme gehandelt am 09.05.2022 und ex Kapitalmassnahme am 10.05.2022 The instrument IXA FR0000030827 IGE + XAO S.A.INH.EO...
► Artikel lesen
03.05.Bulletin from Moberg Pharma's Extraordinary General Meeting on 3 May 2022-
12.04.Notice of Annual General Meeting in Moberg Pharma AB (publ)1
12.04.Moberg Pharma Annual Report for 20211
08.04.Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)-
08.04.Moberg Pharma Sells New Shares for SEK 121 Million at SEK 2.30 per Share159(PLX AI) - Moberg Pharma decides on a fully guaranteed rights issue of approximately SEK 121 million.• The net proceeds will be used for registration activities and clinical work for MOB-015• The subscription...
► Artikel lesen
31.03.Moberg Pharma announces outcome of exercise of warrants of series 2020:1-
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1